Both require once-weekly injections
Here is the incompatibility list
This start enhances feelings of fullness, reduces food intake, slows gastric emptying through mechanisms paired to GLP-1, and helps regulate postprandial glucose levels
Response: Although we acknowledge the applicant's concerns regarding the descriptor for C1739, we do not agree that the device category code should be withdrawn and replaced with a new code effective January 1, 2026, for the following reasons: First, per the applicant's request prior to CY 2026 rulemaking, CMS revised the descriptor for C1739 to read, effective October 1, 2025: Tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system
120 This innovative compound demonstrates dose-dependent efficacy in regulating glycemic control, suppressing appetite, delaying gastric emptying, and facilitating weight reduction
Vitamin C - supports collagen production, and helps combat tiredness and oxidative stress